SARS-CoV-2 coinfections among pertussis cases identified through the Enhanced Pertussis Surveillance system in the United States, January 2020–February 2023
PLOS ONE · 2024
DOI: 10.1371/journal.pone.0311488 ↗Kurz gefasst
Fachartikel in der Zeitschrift PLOS ONE, 2024. Verfasst von Isha Berry und 12 weiteren Autor:innen. Beteiligte Einrichtung: Division of Bacterial Diseases, National Center for Immunization and Respiratory Diseases, Centers for Disease Control and Prevention, Atlanta, Georg…. Hauptthemen laut MEDLINE: Whooping Cough, COVID-19, Coinfection, SARS-CoV-2. Die Arbeit wurde bisher 3-mal zitiert (Crossref) und nennt 17 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC0). Gefördert von: Centers for Disease Control and Prevention.
Abstract (Originalsprache)
Background
Bacterial and viral respiratory coinfections are common, but the prevalence of SARS-CoV-2 infections among pertussis cases has not been estimated. We examine the prevalence and temporality of SARS-CoV-2 infections among pertussis patients and describe pertussis clinical severity among patients with and without SARS-CoV-2 coinfections.
Methods
Confirmed and probable pertussis cases among individuals with cough onset between January 1, 2020 and February 15, 2023 were identified through surveillance in seven Enhanced Pertussis Surveillance (EPS) sites. Pertussis cases with a laboratory-confirmed SARS-CoV-2 infection detected within 30 days before or after pertussis cough onset were defined as coinfections. We describe patient demographics, symptoms, and severe complications and outcomes (seizures, encephalopathy, pneumonia, hospitalization, or death) by coinfection status.
Results
Among 765 pertussis cases reported during the study period, the prevalence of SARS-CoV-2 coinfections was 0.78% [6/765]. Among the six patients meeting the coinfection definition, the majority (83.3% [5/6]) had SARS-CoV-2 infections detected following pertussis cough onset. Compared to those with no known coinfection, a higher proportion of those with coinfections reported severe complications or outcomes (50.0% [3/6] vs. 5.2% [36/694]).
Discussion
Although the prevalence of pertussis patients with SARS-CoV-2 coinfections was low, patients with coinfections reported more severe complications and outcomes compared to those with pertussis alone. Given the decline in reported pertussis cases during the COVID-19 pandemic, continued monitoring of pertussis incidence alongside respiratory viral infections will be important as the pertussis burden returns to pre-pandemic levels.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Autor:innen und Institutionen
- Division of Bacterial Diseases, National Center for Immunization and Respiratory Diseases, Centers for Disease Control and Prevention, Atlanta, Georgia, United States of America.
- Epidemic Intelligence Service, Centers for Disease Control and Prevention, Atlanta, Georgia, United States of America.
- Coronavirus and Other Respiratory Viruses Division, National Center for Immunization and Respiratory Diseases, Centers for Disease Control and Prevention, Atlanta, Georgia, United States of America.
- Colorado Department of Public Health and Environment, Denver, Colorado, United States of America.
- Connecticut Department of Public Health, Hartford, Connecticut, United States of America.
- Georgia Emerging Infections Program, Atlanta, Georgia, United States of America.
ORCID-Profile: Isha Berry, Matthew Cole
Förderung
- Centers for Disease Control and Prevention
Zitieren
APA
Berry, I., Cole, M., Silk, B., Havers, F. P., Youngkin, E., Misiorski, A., Sefton, S., Vang, Y., Stanislawski, E., McGuire, S., Silhan, N., Skoff, T. H., & Rubis, A. B. (2024). SARS-CoV-2 coinfections among pertussis cases identified through the Enhanced Pertussis Surveillance system in the United States, January 2020–February 2023. PLOS ONE. https://doi.org/10.1371/journal.pone.0311488
Vancouver
Berry I, Cole M, Silk B, Havers FP, Youngkin E, Misiorski A, et al. SARS-CoV-2 coinfections among pertussis cases identified through the Enhanced Pertussis Surveillance system in the United States, January 2020–February 2023. PLOS ONE. 2024. doi:10.1371/journal.pone.0311488
BibTeX
@article{Berry2024,
author = {Berry, Isha and Cole, Matthew and Silk, Benjamin and Havers, Fiona P and Youngkin, Erin and Misiorski, Adam and Sefton, Samantha and Vang, Yeng and Stanislawski, Emma and McGuire, Suzanne and Silhan, Noel and Skoff, Tami H and Rubis, Amy B},
title = {SARS-CoV-2 coinfections among pertussis cases identified through the Enhanced Pertussis Surveillance system in the United States, January 2020–February 2023},
journal = {PLOS ONE},
year = {2024},
doi = {10.1371/journal.pone.0311488}
}
EUVIMED